Cargando…
A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small cell lung cancer treated with PD-1 blockade
Evidence from mouse chronic viral infection models suggests that CD8(+) T cell subsets characterized by distinct expression levels of the receptor PD-1 diverge in their state of exhaustion and potential for reinvigoration by PD-1 blockade. However, it remains unknown whether T cells in human cancer...
Autores principales: | Thommen, D.S., Koelzer, V.H., Herzig, P., Roller, A., Trefny, M., Dimeloe, S., Kiialainen, A., Hanhart, J., Schill, C., Hess, C., Savic Prince, S., Wiese, M., Lardinois, D., Ho, P.C., Klein, C., Karanikas, V., Mertz, K.D., Schumacher, T.N., Zippelius, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110381/ https://www.ncbi.nlm.nih.gov/pubmed/29892065 http://dx.doi.org/10.1038/s41591-018-0057-z |
Ejemplares similares
-
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform
por: Koelzer, V.H., et al.
Publicado: (2021) -
PD-1(T) TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC
por: Hummelink, Karlijn, et al.
Publicado: (2022) -
Deciphering molecular and cellular ex vivo responses to bispecific antibodies PD1-TIM3 and PD1-LAG3 in human tumors
por: Natoli, Marina, et al.
Publicado: (2022) -
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer
por: Trüb, Marta, et al.
Publicado: (2020) -
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
por: Trefny, Marcel P., et al.
Publicado: (2023)